Evidence map›Paper›PMID 41515564›Full record

ArticleDiagnostics (Basel, Switzerland)2025

The Diagnostic Performance of a Four-Gene Digital Droplet PCR Panel for Urine Liquid Biopsy in Urothelial Bladder Cancer.

Mark Jain, Alexander Tivtikyan, Dmitry Kislyakov, Tagir Rakhmatullin, David Kamalov, Vladislav Kokarev, Lolita Vorobeva, Larisa Samokhodskaya, Maria Zvereva, Armais Kamalov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The Stalk Sign in Bladder Cancer: CEUS Versus MRI.Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mark JainUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0000-0002-6594-8113
Alexander TivtikyanUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0000-0003-0686-7935
Dmitry KislyakovUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Tagir RakhmatullinUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0000-0002-4601-3478
David KamalovUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Vladislav KokarevFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0009-0009-3024-726X
Lolita VorobevaFaculty of Fundamental Medicine, Lomonosov Moscow State University, 119992 Moscow, Russia.
Larisa SamokhodskayaUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.
Maria ZverevaFaculty of Chemistry, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-7432-1574
Armais KamalovUniversity Clinic, Lomonosov Moscow State University, 119992 Moscow, Russia.ORCID 0000-0003-4251-7545

Funding

Lomonosov Moscow State University The study was conducted under the state assignment of Lomonosov Moscow State University
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancercell-free DNAFGFR3GPR126liquid biopsymutationsPIK3CATERTurineurothelial cancer

Identifiers

PMID41515564
PMCPMC12785868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.